Selected Industry Projects

• Antihypertensive agents: amlodipine, ramipril – Phase 3 reports
• Anti-infectives: azithromycin, linezolid – Phase 3 reports, quality control
• Antiplatelet agent: clopidogrel – Phase 1 reports
• Antithrombotic: factor Xa inhibitor – Phase 1 reports
• Breast cancer: fulvestrant – Informed consent document
• Diabetes: troglitazone – Phase 3 reports
• Esophageal cancer: nimotuzumab – Protocol
• Global Innovate!! implementation of progressive business ideas
• Hormone replacement: norethindrone acetate/ethinyl estradiol – Phase 3 reports
• Hypercholesterolemia: torcetrapib / atorvastatin – Phase 2 reports
• Neuropathic pain: gabapentin, pregabalin – Phase 3 reports, safety narratives
• Renal disease: mycophenolate sodium – Protocol
• Selective estrogen receptor modulator (SERM): lasofoxifene – Phase 2/3 reports
• Smoking cessation: varenicline – Phase 3 reports
• Workshops: Clinical Study Reports, GCP, ICH and the Declaration of Helsinki, Informed Consent, Search Strategies, Statistics in Medicine.